8-K: Oxford Square Capital Reports Q2 2025 Results

Sentiment:

Quarterly Financial Results


Oxford Square Capital Corp. announced its second quarter 2025 financial results, reporting a decrease in net asset value and net investment income per share, while declaring distributions for the upcoming months.

Capital raiseIssued approximately 4.9 million shares of common stock pursuant to an at-the-market offering.Resulted in net proceeds of approximately $11.6 million after deducting sales agents commissions and offering expenses.
Worse than expectedNet asset value per share decreased from $2.09 to $2.06 quarter-over-quarter.Net investment income per share decreased from $0.09 to $0.08 quarter-over-quarter.Total investment income decreased from $10.2 million to $9.5 million quarter-over-quarter.Weighted average effective yield of CLO equity investments decreased from 9.0% to 8.8% quarter-over-quarter.Weighted average cash distribution yield of senior secured note investments decreased from 9.7% to 9.0% quarter-over-quarter.Weighted average cash distribution yield of CLO equity investments decreased from 15.5% to 13.8% quarter-over-quarter.Net unrealized appreciation significantly decreased to $1.3 million for Q2 2025 compared to $28.0 million for Q2 2024.

Summary

  • Net asset value (NAV) per share decreased to $2.06 as of June 30, 2025, from $2.09 on March 31, 2025.
  • Net investment income (NII) for Q2 2025 was approximately $5.5 million, or $0.08 per share, down from $6.1 million, or $0.09 per share, in Q1 2025.
  • Total investment income for Q2 2025 amounted to approximately $9.5 million, compared with approximately $10.2 million for Q1 2025.
  • Total expenses for Q2 2025 were approximately $4.0 million, a slight decrease from $4.1 million in Q1 2025.
  • The company declared distributions of $0.035 per share for each of October, November, and December 2025.
  • Net increase in net assets resulting from operations was approximately $4.4 million for Q2 2025, consisting of $5.5 million NII, $2.4 million net realized losses, and $1.3 million net unrealized appreciation.
  • During Q2 2025, the company issued approximately 4.9 million shares of common stock through an at-the-market offering, generating net proceeds of approximately $11.6 million.

Sentiment

Score: 4

Explanation: While expenses were slightly lower and distributions were maintained, the decline in Net Asset Value per share, Net Investment Income per share, and several key investment yields indicates a weakening in core operational performance. The significant drop in net unrealized appreciation compared to the prior year also contributes to a cautious outlook.

Positives

  • Total expenses slightly decreased to approximately $4.0 million in Q2 2025 from $4.1 million in Q1 2025.
  • The weighted average yield of debt investments increased to 14.5% at current cost as of June 30, 2025, from 14.3% as of March 31, 2025.
  • Net realized losses significantly decreased to approximately $2.4 million for Q2 2025, compared to $30.4 million for Q2 2024.
  • The company successfully raised approximately $11.6 million in net proceeds from an at-the-market common stock offering during Q2 2025.
  • Distributions of $0.035 per share were declared for October, November, and December 2025, maintaining the previous distribution rate.

Negatives

  • Net asset value (NAV) per share decreased to $2.06 as of June 30, 2025, from $2.09 as of March 31, 2025.
  • Net investment income (NII) decreased to approximately $5.5 million ($0.08 per share) for Q2 2025, from $6.1 million ($0.09 per share) for Q1 2025.
  • Total investment income decreased to approximately $9.5 million for Q2 2025, from $10.2 million for Q1 2025.
  • The weighted average effective yield of CLO equity investments decreased to 8.8% at current cost as of June 30, 2025, from 9.0% as of March 31, 2025.
  • The weighted average cash distribution yield of cash income producing senior secured note investments decreased to 9.0% at current cost as of June 30, 2025, from 9.7% as of March 31, 2025.
  • The weighted average cash distribution yield of cash income producing CLO equity investments decreased to 13.8% at current cost as of June 30, 2025, from 15.5% as of March 31, 2025.
  • Preferred equity investments in one portfolio company with an aggregate fair value of approximately $5.0 million were on non-accrual status as of June 30, 2025.
  • Net unrealized appreciation decreased significantly to approximately $1.3 million for Q2 2025, compared to $28.0 million for Q2 2024.

Risks

  • Forward-looking statements are subject to inherent uncertainties in predicting future results and conditions, and certain factors could cause actual results and conditions to differ materially from those projected.

Future Outlook

The company declared distributions of $0.035 per share for the months ending October 31, 2025, November 30, 2025, and December 31, 2025. A conference call to discuss second quarter results was scheduled for August 7, 2025.

Industry Context

NA

Related Party Transactions

  • Base Fee and Net Investment Income Incentive Fee payable to affiliate of $1,036,312 for the quarter ended June 30, 2025.

Stakeholder Impact

  • Shareholders: Impacted by decreased NAV per share and NII per share, but distributions are maintained. Potential dilution from the at-the-market offering.
  • Creditors: No direct impact mentioned, but financial performance could indirectly affect creditworthiness.

Next Steps

  • Conference call to discuss second quarter results on August 7, 2025, at 9:00 AM ET.
  • Distributions declared for October, November, and December 2025.
  • Supplemental investor information available on the company's website.

Key Dates

DateDescription
June 30, 2025End of the second fiscal quarter for which financial results are reported.
July 30, 2025Board of Directors declared distributions on common stock.
August 7, 2025Date of the 8-K report and press release issuance; supplemental investor information made available; conference call held to discuss results.
October 17, 2025Record date for the distribution for the month ending October 31, 2025.
October 31, 2025Payment date for the distribution for the month ending October 31, 2025.
November 14, 2025Record date for the distribution for the month ending November 30, 2025.
November 28, 2025Payment date for the distribution for the month ending November 30, 2025.
December 17, 2025Record date for the distribution for the month ending December 31, 2025.
December 31, 2025Payment date for the distribution for the month ending December 31, 2025.

Recommendation

hold

The company reported a decline in key performance indicators such as Net Asset Value per share and Net Investment Income per share, alongside reduced yields on several investment categories. While expenses were slightly lower and distributions were maintained, the overall trend in core earnings and asset value is negative. The at-the-market offering raised capital but also increased shares outstanding, potentially diluting per-share metrics. An investor would likely hold to observe if the company can reverse the declining trends in NAV and NII in future quarters, especially given the maintained distributions, but would not recommend a strong buy due to the current performance.

Keywords

Business Development Company, BDC, CLO, Collateralized Loan Obligation, Syndicated Bank Loans, Investment Income, Net Asset Value, Distributions, Financial Results, OXSQ, Quarterly Earnings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.